Senzime AB (publ) (STO:SEZI)
4.575
-0.060 (-1.29%)
May 25, 2026, 5:29 PM CET
Senzime AB Revenue
Senzime AB had revenue of 23.23M SEK in the quarter ending March 31, 2026, a decrease of -1.13%. This brings the company's revenue in the last twelve months to 103.76M, up 48.53% year-over-year. In the year 2025, Senzime AB had annual revenue of 104.02M with 77.89% growth.
Revenue (ttm)
103.76M
Revenue Growth
+48.53%
P/S Ratio
7.02
Revenue / Employee
1.76M
Employees
59
Market Cap
728.69M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 104.02M | 45.55M | 77.89% |
| Dec 31, 2024 | 58.48M | 22.72M | 63.55% |
| Dec 31, 2023 | 35.75M | 21.72M | 154.77% |
| Dec 31, 2022 | 14.03M | 3.05M | 27.81% |
| Dec 31, 2021 | 10.98M | 1.64M | 17.60% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| BICO Group AB | 1.49B |
| C-Rad AB | 427.80M |
| Paxman AB | 344.91M |
| Mentice AB | 286.97M |
| Devyser Diagnostics AB | 257.50M |
| Bactiguard Holding AB | 201.18M |
| Sedana Medical AB | 196.15M |
| OssDsign AB | 172.55M |
Senzime AB News
- 6 days ago - Bulletin From Annual General Meeting in Senzime AB (publ) - Accesswire
- 26 days ago - Senzime Strengthens U.S. Operations with New Leadership Appointments - Accesswire
- 4 weeks ago - Senzime's TetraGraph System Contracted on Three Leading GPO Agreements in the US - Accesswire
- 4 weeks ago - Senzime Publishes Annual and Sustainability Report for 2025 - Accesswire
- 4 weeks ago - Margins Strengthened and Cash Flow Improved Despite a Temporary Dip in The Growth Trajectory. Full-Year Targets Remain on Track - Accesswire
- 4 weeks ago - Senzime AB Quarterly report: Q1 2026 - Filings
- 4 weeks ago - Senzime AB Slides: Q1 2026 - Filings
- 4 weeks ago - Senzime AB Quarterly report: Q1 2026 - Filings